Prem Watsa's position in Pfizer is currently worth $25.8M. That's 1.17% of their equity portfolio (15th largest holding). The first Pfizer trade was made in Q2 2007. Since then Prem Watsa bought shares ten more times and sold shares on five occasions. The investor's estimated purchase price is $31.5M, resulting in a loss of 18%.